State Street Corp Ikena Oncology, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, State Street Corp holds 80,353 shares of IKNA stock, worth $122,940. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,353

Previous 80,353 -0.0%

Holding current value

$122,940

Previous $132,000 5.3%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.24 - $1.82 $498,842 - $732,171	-402,292 Reduced 83.35%	80,353 $132,000
Q1 2024 May 15, 2024	BUY	$1.27 - $2.0 $91,313 - $143,800	71,900 Added 17.5%	482,645 $685,000
Q4 2023 Feb 14, 2024	BUY	$1.33 - $4.4 $18,221 - $60,280	13,700 Added 3.45%	410,745 $809,000
Q3 2023 Nov 14, 2023	BUY	$4.09 - $6.43 $53,951 - $84,818	13,191 Added 3.44%	397,045 $1.72 Million
Q2 2023 Aug 14, 2023	BUY	$3.5 - $7.31 $1.13 Million - $2.37 Million	323,901 Added 540.26%	383,854 $2.52 Million
Q1 2023 May 15, 2023	BUY	$2.62 - $4.97 $24,104 - $45,724	9,200 Added 18.13%	59,953 $206,000
Q4 2022 Feb 14, 2023	BUY	$2.0 - $3.7 $38,400 - $71,040	19,200 Added 60.85%	50,753 $135,000
Q3 2022 Nov 15, 2022	SELL	$3.46 - $6.0 $43,952 - $76,218	-12,703 Reduced 28.7%	31,553 $112,000
Q2 2022 Aug 15, 2022	SELL	$3.23 - $7.4 $1.16 Million - $2.67 Million	-360,346 Reduced 89.06%	44,256 $196,000
Q1 2022 May 16, 2022	BUY	$5.61 - $13.85 $358,972 - $886,233	63,988 Added 18.79%	404,602 $2.47 Million
Q4 2021 Feb 14, 2022	BUY	$10.52 - $16.96 $2.19 Million - $3.53 Million	208,146 Added 157.13%	340,614 $4.27 Million
Q3 2021 Nov 15, 2021	BUY	$9.82 - $15.23 $550,077 - $853,123	56,016 Added 73.27%	132,468 $1.67 Million
Q2 2021 Aug 16, 2021	BUY	$13.27 - $26.0 $1.01 Million - $1.99 Million	76,452 New	76,452 $1.07 Million

Others Institutions Holding IKNA

# of Institutions

Shares Held

30.6M

Call Options Held

Put Options Held

View Full List

About Ikena Oncology, Inc.

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $55.5M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

More about IKNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Ikena Oncology, Inc. Transaction History